About
Technology
Issues
FAQ
Links
Official Page
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.